TABLE OF CONTENTS
Volume 40, Issue 2 (July (2) 2007)
Review
T cell therapies following hematopoietic stem cell transplantation: surely there must be a better way than DLI? FREE
A A Kennedy-Nasser and C M Bollard
Bone Marrow Transplant 40: 93-104; advance online publication, May 14, 2007; doi:10.1038/sj.bmt.1705667
Original Articles
Conditioning Regimens
Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients FREE
M Iravani, M R Evazi, S A Mousavi, A R Shamshiri, M Tavakoli, A Ashouri, S Samiee, B Chahardovali, K Alimoghaddam, S H Ghaffari and A Ghavamzadeh
Bone Marrow Transplant 40: 105-110; advance online publication, April 30, 2007; doi:10.1038/sj.bmt.1705685
Cell Procurement
Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma FREE
M Tomblyn, L J Burns, B Blazar, J Wagner, C Lee, T Rogers, P McGlave, J S Miller and D J Weisdorf
Bone Marrow Transplant 40: 111-118; advance online publication, May 28, 2007; doi:10.1038/sj.bmt.1705708
Allografting
Outpatient allografting using non-myeloablative conditioning: the Mexican experience FREE
O G Cantú-Rodríguez, J C Jaime-Pérez, C H Gutiérrez-Aguirre, O González-Llano, C Mancías-Guerra, L C Tarín-Arzaga, G J Ruiz-Delgado, C C Sandoval-Villa, J Marfil-Rivera, A Morales-Toquero, G J Ruiz-Argüelles and D Gómez-Almaguer
Bone Marrow Transplant 40: 119-123; advance online publication, May 28, 2007; doi:10.1038/sj.bmt.1705700
Post-Transplant Events
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies FREE
E Özdemir, R M Saliba, R E Champlin, D R Couriel, S A Giralt, M de Lima, I F Khouri, C Hosing, S M Kornblau, P Anderlini, E J Shpall, M H Qazilbash, J J Molldrem, R F Chemaly and K V Komanduri
Bone Marrow Transplant 40: 125-136; advance online publication, May 28, 2007; doi:10.1038/sj.bmt.1705699
Comparable incidence and severity of cytomegalovirus infections following T cell-depleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning FREE
J S Kalpoe, P L J van der Heiden, N Vaessen, E C J Claas, R M Barge and A C M Kroes
Bone Marrow Transplant 40: 137-143; advance online publication, May 28, 2007; doi:10.1038/sj.bmt.1705701
The presence of functional CCR5 and EBV reactivation after allogeneic haematopoietic stem cell transplantation FREE
K Bogunia-Kubik, E Jaskula and A Lange
Bone Marrow Transplant 40: 145-150; advance online publication, May 28, 2007; doi:10.1038/sj.bmt.1705703
Antibiotic cycling to decrease bacterial antibiotic resistance: a 5-year experience on a bone marrow transplant unit FREE
J Cadena, C A Taboada, D S Burgess, J Z Ma, J S Lewis II, C O Freytes and J E Patterson
Bone Marrow Transplant 40: 151-155; advance online publication, May 28, 2007; doi:10.1038/sj.bmt.1705704
A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation FREE
M A Slavin, A P Grigg, A P Schwarer, J Szer, A Spencer, A Sainani, K A Thursky and A W Roberts
Bone Marrow Transplant 40: 157-163; advance online publication, April 30, 2007; doi:10.1038/sj.bmt.1705686
Pre-Clinical Studies
The HLA-A*0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A*0206 FREE
H Torikai, Y Akatsuka, H Miyauchi, S Terakura, M Onizuka, K Tsujimura, K Miyamura, Y Morishima, Y Kodera, K Kuzushima and T Takahashi
Bone Marrow Transplant 40: 165-174; advance online publication, May 28, 2007; doi:10.1038/sj.bmt.1705689
Letters to the Editor
Long-term graft-versus-Waldenström macroglobulinemia effect following reduced intensity conditioning allogeneic stem cell transplantation FREE
J-C Meniane, J El-Cheikh, C Faucher, S Fürst, R Bouabdallah, D Blaise and M Mohty
Bone Marrow Transplant 40: 175-177; advance online publication, May 14, 2007; doi:10.1038/sj.bmt.1705702
Relevance of drug allergy history after allogeneic hemopoietic stem cell transplantation FREE
W Y Au
Bone Marrow Transplant 40: 179-180; advance online publication, May 28, 2007; doi:10.1038/sj.bmt.1705705
Chimerism does not predict for outcome after alemtuzumab based conditioning FREE
L Michaelis, S Lin, L Joseph, A S Artz, J Kline, D Pollyea, W Stock, E Rich, D Collins-Jones, B Casey, P Del Cerro and K van Besien
Bone Marrow Transplant 40: 181; advance online publication, May 14, 2007; doi:10.1038/sj.bmt.1705707
